| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1995* | 2020 |
| Deciphering cell–cell interactions and communication from gene expression E Armingol, A Officer, O Harismendy, NE Lewis Nature Reviews Genetics 22 (2), 71-88, 2021 | 985 | 2021 |
| Evaluation of next generation sequencing platforms for population targeted sequencing studies O Harismendy, PC Ng, RL Strausberg, X Wang, TB Stockwell, KY Beeson, ... Genome biology 10, 1-13, 2009 | 786 | 2009 |
| 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response O Harismendy, D Notani, X Song, NG Rahim, B Tanasa, N Heintzman, ... Nature 470 (7333), 264-268, 2011 | 768 | 2011 |
| Microdroplet-based PCR enrichment for large-scale targeted sequencing R Tewhey, JB Warner, M Nakano, B Libby, M Medkova, PH David, ... Nature biotechnology 27 (11), 1025-1031, 2009 | 715 | 2009 |
| Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling G He, D Dhar, H Nakagawa, J Font-Burgada, H Ogata, Y Jiang, ... Cell 155 (2), 384-396, 2013 | 508 | 2013 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 456 | 2020 |
| FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors E Shi, J Chmielecki, CM Tang, K Wang, MC Heinrich, G Kang, CL Corless, ... Journal of translational medicine 14, 1-11, 2016 | 224 | 2016 |
| Deep mining heterogeneous networks of biomedical linked data to predict novel drug–target associations N Zong, H Kim, V Ngo, O Harismendy Bioinformatics 33 (15), 2337-2344, 2017 | 204 | 2017 |
| Genome‐wide location of yeast RNA polymerase III transcription machinery O Harismendy, CG Gendrel, P Soularue, X Gidrol, A Sentenac, M Werner, ... The EMBO journal, 2003 | 189 | 2003 |
| iPSCORE: a resource of 222 iPSC lines enabling functional characterization of genetic variation across a variety of cell types AD Panopoulos, M D'Antonio, P Benaglio, R Williams, SI Hashem, ... Stem cell reports 8 (4), 1086-1100, 2017 | 184 | 2017 |
| Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy V Wu, H Yeerna, N Nohata, J Chiou, O Harismendy, F Raimondi, A Inoue, ... Journal of Biological Chemistry 294 (29), 11062-11086, 2019 | 177 | 2019 |
| General repression of RNA polymerase III transcription is triggered by protein phosphatase type 2A-mediated dephosphorylation of Maf1 D Oficjalska-Pham, O Harismendy, WJ Smagowicz, AG de Peredo, ... Molecular cell 22 (5), 623-632, 2006 | 177 | 2006 |
| Method for improving sequence coverage uniformity of targeted genomic intervals amplified by LR-PCR using Illumina GA sequencing-by-synthesis technology O Harismendy, KA Frazer Biotechniques 46 (3), 229-231, 2009 | 161 | 2009 |
| Enrichment of sequencing targets from the human genome by solution hybridization R Tewhey, M Nakano, X Wang, C Pabón-Peña, B Novak, A Giuffre, E Lin, ... Genome biology 10, 1-13, 2009 | 157 | 2009 |
| Use of liquid biopsies in clinical oncology: pilot experience in 168 patients M Schwaederle, H Husain, PT Fanta, DE Piccioni, S Kesari, RB Schwab, ... Clinical cancer research 22 (22), 5497-5505, 2016 | 149 | 2016 |
| Biomarkers of endocannabinoid system activation in severe obesity JC Sipe, TM Scott, S Murray, O Harismendy, GM Simon, BF Cravatt, ... PloS one 5 (1), e8792, 2010 | 138 | 2010 |
| Accurate detection and genotyping of SNPs utilizing population sequencing data V Bansal, O Harismendy, R Tewhey, SS Murray, NJ Schork, EJ Topol, ... Genome research 20 (4), 537-545, 2010 | 134 | 2010 |
| Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin H Alakus, ML Babicky, P Ghosh, S Yost, K Jepsen, Y Dai, A Arias, ... Genome medicine 6, 1-11, 2014 | 130 | 2014 |
| Nrf2 induces IL-17D to mediate tumor and virus surveillance R Saddawi-Konefka, R Seelige, ETE Gross, E Levy, SC Searles, ... Cell reports 16 (9), 2348-2358, 2016 | 129 | 2016 |
Kelly A. FrazerUniversity of California, San DiegoAdresse e-mail validée de health.ucsd.edu
